Spot Trading’s bluebird bio BLUE Stock Holding History

Spot Trading’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.46M	Buy	818 +741	+962%	+$1.04M	0.03%	914
2017 Q2	$105K	Buy	77 +23	+43%	+$27.8K	﹤0.01%	2574
2017 Q1	$64K	Sell	54 -1,135	-95%	-$1.16M	﹤0.01%	2421
2016 Q4	$950K	Buy	1,189 +100	+9%	+$79.4K	0.02%	984
2016 Q3	$956K	Buy	1,089 +996	+1,071%	+$721K	0.02%	1098
2016 Q2	$52K	Sell	93 -61	-40%	-$34.5K	﹤0.01%	2746
2016 Q1	$85K	Sell	154 -687	-82%	-$422K	﹤0.01%	2633
2015 Q4	$700K	Sell	841 -873	-51%	-$872K	0.01%	1688
2015 Q3	$1.9M	Buy	1,714 +595	+53%	+$1.08M	0.02%	1116
2015 Q2	$2.44M	Buy	1,119 +1,026	+1,103%	+$2.09M	0.02%	1014
2015 Q1	$145K	Sell	93 -625	-87%	-$825K	﹤0.01%	2938
2014 Q4	$853K	Sell	718 -826	-53%	-$552K	0.01%	1990
2014 Q3	$718K	Buy	+1,544	New	+$712K	﹤0.01%	2313

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Spot Trading's BLUE Position: Q3 2017 in Review

Spot Trading increased its bluebird bio (BLUE) stake by 36% in Q3 2017, buying an estimated $110K and bringing the position to 300 shares worth $535K. The position accounts for 0.01% of the portfolio, ranked #1598.

Spot Trading first reported a position in BLUE in Q3 2014 and has held it in 11 quarters since. The position peaked at $844K in Q3 2016. 243 funds tracked by Wall St. Rank hold BLUE as of Q3 2017.

Spot Trading held 300 shares of bluebird bio worth $535K as of Q3 2017.
Spot Trading bought 79 bluebird bio shares in Q3 2017, an estimated $110K.
bluebird bio made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1598 holding.
Spot Trading first reported a position in bluebird bio in Q3 2014 and has held it in 11 quarters since.
Spot Trading's bluebird bio position peaked at $844K in Q3 2016.
243 funds tracked by Wall St. Rank held bluebird bio as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.